Trial Profile
Efficacy evaluation on switching to 50mg of minodronic acid hydrate in patients with osteoporosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Mar 2018
Price :
$35
*
At a glance
- Drugs Minodronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 13 Mar 2018 Status changed from recruiting to completed.
- 13 Nov 2013 New trial record